The cytotoxic degranulation of NK cells was determined by measuring the cell surface expression of CD107a, as previously described [35]. Briefly, IL-2-stimulated PBMCs or primary expanded NK cells (1 × 105 cells) were mixed with an equal number of KCL-22 M cells in 96-well V-bottom culture plates (Corning Costar, NY, USA) and incubated for 2 h at 37 °C. For the blockade of NK activating receptors, Fc receptors on IL-2-stimulated PBMCs or primary expanded NK cells were blocked with human Fc Receptor Binding Inhibitor (eBioscience, San Diego, CA, USA) and then incubated with 20 μg/mL control IgG1 or Abs to the indicated NK activating receptors for 30 min at 4 °C prior to mixing with target cells. The cell pellets were resuspended in flow cytometry buffer (phosphate-buffered saline [PBS] with 1% FBS) and stained with anti-human CD3-PerCP, anti-human CD56-PE, and anti-human CD107a-FITC Abs for 35 min in the dark at 4 °C. Lymphocytes were gated on forward and side scatter characteristics, and the CD107a expression on CD3−CD56+ NK cells was analyzed by flow cytometry using a FACS Accuri C6 (BD Biosciences, Franklin Lakes, NJ, USA) and FlowJo software (ver.10, Treestar, Ashland, OR, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.